Search Results

Your search for AstraZeneca in News Releases returned 3 results

News Releases

• May 13, 2013, 15:00 ET

  Assessing Your Asthma is Key to Taking Control

  Approximately 25 million Americans suffer from asthma, which accounts for more than 3300 deaths each year. AstraZeneca (NYSE: AZN) is urging Americans to embrace National Asthma & Allergy Awareness Month this May by taking proactive steps to gain control of their asthma and learn more about...

  More news about: AstraZeneca

• Apr 05, 2013, 02:01 ET

  AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis

  

   AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase (SYK) inhibitor in development for rheumatoid arthritis (RA).  OSKIRA-1 had two primary endpoints: assessing signs and...

  More news about: Rigel Pharmaceuticals, Inc. , AstraZeneca

• Mar 25, 2013, 03:15 ET

  Actavis Reaches Agreement with AstraZeneca to Launch a Generic Version of Crestor® in 2016

  

   Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic...

  More news about: Actavis, Inc. , AstraZeneca